Related Experiment Video
Updated: May 14, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis
Meryem Bektas1, Puneet S Jolly, Paula Berkowitz
1Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599-7287, USA.
Pemphigus vulgaris (PV) IgG activates EGF receptor (EGFR) in skin cells, leading to cell damage. Inhibiting EGFR prevents PV-induced blistering, suggesting EGFR inhibitors as a potential pemphigus treatment.
Area of Science:
- Dermatology
- Immunology
- Cell Biology
Background:
- Pemphigus is an autoimmune disease targeting desmogleins (dsg1/dsg3).
- The role of epidermal growth factor receptor (EGFR) signaling in pemphigus pathogenesis is unclear.
Purpose of the Study:
- To investigate the role of EGFR in pemphigus vulgaris (PV) pathogenesis.
- To explore EGFR as a potential therapeutic target for pemphigus.
Main Methods:
- Primary human keratinocytes were treated with PV IgG.
- EGFR activation and downstream effects (dsg3 endocytosis, cell adhesion) were assessed.
- Inhibition of EGFR and p38 mitogen-activated protein kinase (p38) was performed.
- A passive transfer mouse model of pemphigus was used to evaluate blister formation.
Main Results:
- PV IgG activated EGFR in keratinocytes, downstream of p38.
- EGFR inhibition blocked PV IgG-induced dsg3 endocytosis, keratin retraction, and loss of cell adhesion.
- EGFR inhibition prevented PV IgG-induced blister formation in mice.
Conclusions:
- Cross-talk exists between dsg3 and EGFR in pemphigus pathogenesis, regulated by p38.
- EGFR is a critical mediator of PV-induced keratinocyte damage and blister formation.
- EGFR inhibitors represent a promising therapeutic strategy for pemphigus.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
Renewal of Skin Epidermal Stem Cells
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
